AChE activity is a hallmark for the assessment of neuronal cholinergic neurotransmission and AchE activities, leading to a reduction in the acetylcholine contents in neuronal tissue and causing cognitive dysfunction in diabetic VaD and AD patients [30]. This evidence concerns the gene ACHE and Alzheimer disease.